Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-11-21 to 2024-12-13
Current total value of award: $28258.05
Description: 4566555351!XOLAIR 300 MG/2 ML SYRINGE 2ML